Found: 5
Select item for more details and to access through your institution.
The first selective VAP-1 inhibitor in China, TT-01025-CL: safety, tolerability, pharmacokinetics, and pharmacodynamics of singleand multiple-ascending doses.
- Published in:
- Frontiers in Pharmacology, 2024, p. 01, doi. 10.3389/fphar.2024.1327008
- By:
- Publication type:
- Article
Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis.
- Published in:
- Liver International, 2020, v. 40, n. 3, p. 622, doi. 10.1111/liv.14316
- By:
- Publication type:
- Article
TP53 Mutations Promote Immunogenic Activity in Breast Cancer.
- Published in:
- Journal of Oncology, 2019, p. 1, doi. 10.1155/2019/5952836
- By:
- Publication type:
- Article
Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice.
- Published in:
- Marine Drugs, 2019, v. 17, n. 8, p. 391, doi. 10.3390/md17070391
- By:
- Publication type:
- Article
Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice.
- Published in:
- Marine Drugs, 2019, v. 17, n. 7, p. 391, doi. 10.3390/md17070391
- By:
- Publication type:
- Article